Weekly events giving members the opportunity to meet with journalists online and pitch their story ideas.

“I haven’t enjoyed getting a pitch this much in, well…ever!” — Ben Gruber, Reuters


Expert Panel: Study of fecal microbiota on patients with C. diff infection

Researchers will discuss their findings in a new study on the efficacy and safety of fecal microbiota to prevent recurrent Clostridioides difficile infection in real world patients.

Wednesday, May 3, 2023, 4:00pm - 5:00pm EDT


The first microbiota-based live biotherapeutic approved by the US FDA used to prevent recurrent Clostridioides difficile infection (rCDI) in adults, has been evaluated in 5 prospective clinical trials. A retrospective analysis considered the safety and efficacy of FMBL administered under US FDA enforcement discretion to patients with rCDI.

Registration is closed for this event.

For more information or questions, please email:

[email protected]